Pharmacology of serotonin: what a clinician should know.
about
Serotonin augments gut pacemaker activity via 5-HT3 receptorsThe effect of the menstrual cycle on inflammatory bowel disease: a prospective study.Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicinePrucalopride: the evidence for its use in the treatment of chronic constipation.Expression of 5-HT3 receptors and TTX resistant sodium channels (Na(V)1.8) on muscle nerve fibers in pain-free humans and patients with chronic myofascial temporomandibular disorders.Review article: current and emerging therapies for functional dyspepsia.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion.Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouseAssociation study of serotonin transporter SLC6A4 gene with Chinese Han irritable bowel syndrome.Emerging drugs for gastro-oesophageal reflux disease.Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation.Drug development for the irritable bowel syndrome: current challenges and future perspectivesDual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis.Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.5-HT receptors on interstitial cells of Cajal, smooth muscle and enteric nerves.Human 5-HT(4) and 5-HT(7) receptor splice variants: are they important?Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in ratsPathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside.The Anti-Inflammatory Effect of Guchangzhixie-Pill by Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in an Ulcerative Colitis Rat Model.Telotristat ethyl: a new option for the management of carcinoid syndrome.5-hydroxytryptamine generates tonic inward currents on pacemaker activity of interstitial cells of cajal from mouse small intestine.Does Cisapride, as a 5HT(4) Receptor Agonist, Aggravate the Severity of TNBS-Induced Colitis in Rat?Stimulation of contractions in human myometrium by serotonin is unmasked by smooth muscle relaxants.5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors.Gene Expression Profiling and Assessment of Vitamin D and Serotonin Pathway Variations in Patients With Irritable Bowel Syndrome.Localization of the 5-hydroxytryptamine 4 receptor in equine enteric neurons and extrinsic sensory fibers.Toll-like receptors 2 and 4 exert opposite effects on the contractile response induced by serotonin in mouse colon: role of serotonin receptors.Toll-like receptors 2 and 4 modulate the contractile response induced by serotonin in mouse ileum: analysis of the serotonin receptors involved.Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders.Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome
P2860
Q27319848-BCB14556-5925-45B7-9D85-3233AA3D071DQ33457198-EBE21BFA-A26B-4DCA-9265-F5B1B2FA4264Q33735229-A512C2D2-F24F-451A-8F2D-9F8AE2C19E65Q33973983-E2F3D793-0CDF-47A4-8DB6-A77B0358E20AQ34277149-440ECBAF-91DE-468F-BACF-735D58025531Q34553942-3D279047-C450-4857-88E4-B3898E35DF7EQ34626602-A01AD3D1-B51D-4E0E-9E52-D805FE798F51Q34946618-A3BFA8BD-9AE6-4BC7-A871-7EF5DB9F1A14Q35049360-64EA7C3B-064C-4D06-80B8-EB13E6983F22Q35083388-E58B5D93-A716-499E-8CDE-28FDC8F4A884Q36150665-2BE9EE6D-E855-4D95-BB26-FD547013C887Q36321320-D8DD7DFD-7171-48D9-803B-6A8FEAA15C61Q36579818-F0E18FE0-E73D-49DB-8194-FF787BFDA9A5Q36713342-C930DCB9-4139-4E8C-ABB9-ADA9E8C69849Q36728938-3307EE18-B043-42E3-A36B-F5ADEFE46AF4Q36874372-99F4434F-4584-407A-A9F2-D86860756E64Q37420451-9EC79BD6-3229-4D30-A001-BD302DC9CE9CQ37434409-0E67259F-A9FD-4060-9DF5-627ABB9C0D94Q37677017-547A6C8C-2ACF-4F96-907B-E6838DBC8D84Q38175457-88E276AC-CFB0-463D-986D-859852150D8AQ38197845-6DA89E01-E1C1-44DA-ACD6-DD21E50B257CQ38248113-C2F12F4E-5CBD-4C5B-A13A-E3292108A505Q38606277-82A65A59-1E8D-4CFE-A1AF-7484AD0920BAQ39000212-858B9F6A-0FC0-4CE6-8F77-277E24DA39CAQ42134885-ADDCCD5A-DEEA-45B9-AE2A-83561E57A21AQ42255978-6917F989-B441-4139-9898-C3338A9E8F75Q46533280-033C14A3-C0BE-4A8B-A719-4EC7DA65B4E5Q46721499-A493770A-075C-4D02-9109-CB48AE46A267Q47124358-7364D5D8-C184-40A4-9069-9BFC5779EB71Q48168717-1F2C1E01-C907-4603-8DA9-16F8C164BC8FQ48206498-83432F31-27DA-402C-A609-58B60D375826Q53474757-EFD80EFF-4BAB-433E-83ED-3091B7F3837EQ55527145-46B6744D-8337-4FC5-A628-8177E76A0F92Q56985161-8FF27ECD-8DEA-4ABE-8645-B9171F1EF443
P2860
Pharmacology of serotonin: what a clinician should know.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacology of serotonin: what a clinician should know.
@ast
Pharmacology of serotonin: what a clinician should know.
@en
type
label
Pharmacology of serotonin: what a clinician should know.
@ast
Pharmacology of serotonin: what a clinician should know.
@en
prefLabel
Pharmacology of serotonin: what a clinician should know.
@ast
Pharmacology of serotonin: what a clinician should know.
@en
P2860
P356
P1433
P1476
Pharmacology of serotonin: what a clinician should know
@en
P2093
F De Ponti
P2860
P304
P356
10.1136/GUT.2003.035568
P407
P577
2004-10-01T00:00:00Z